Thiamine Deficiency: An Important Consideration in Critically Ill Patients

Area of Science:

• Biochemistry
• Critical Care Medicine

Background:

• Thiamine (vitamin B1) is vital for energy production and synthesis of cellular molecules.
• Body thiamine stores are limited, making deficiency a risk in various clinical settings.
• Thiamine deficiency is prevalent in sepsis and post-surgical patients.

Purpose of the Study:

• To highlight the significance of thiamine deficiency in intensive care unit (ICU) patients.
• To underscore the potential complications arising from thiamine deficiency in critical illness.
• To emphasize the clinical need for considering thiamine status in ICU management.

Main Methods:

• Review of existing literature on thiamine's role and deficiency in critical care.
• Analysis of clinical manifestations and complications associated with thiamine deficiency.
• Evaluation of thiamine's therapeutic potential in critical illness.

Main Results:

• Thiamine deficiency can precipitate heart failure, neuropathy (including Wernicke's encephalopathy), and gastrointestinal issues.
• Deficiency contributes to ICU complications such as delirium, critical care neuropathy, and unexplained lactic acidosis.
• Intravenous thiamine administration shows promise in correcting lactic acidosis, enhancing cardiac function, and resolving delirium.

Conclusions:

• Clinicians must actively consider and assess for thiamine deficiency in ICU patients.
• Prompt recognition and management of thiamine deficiency are essential for mitigating severe complications.
• Intravenous thiamine is a viable therapeutic option for specific critical care-related conditions.